1. Executive Summary (Confidence: high)

Aeon is at the forefront of the "Longevity as a Service" movement, providing individuals with a level of diagnostic depth usually reserved for advanced clinical research or symptomatic crisis management. The platform offers multiparametric whole-body MRI scans—which are radiation-free and do not require contrast agents—integrated with a panel of up to 75+ blood biomarkers. By utilizing AI for body composition and brain health analysis, Aeon transitions healthcare from a reactive model to a predictive one. Based in Switzerland and expanding into Germany and the UAE, Aeon targets high-net-worth individuals and proactive consumers willing to invest in early detection to extend their healthy life expectancy.